Muthoot Microfin standalone PAT surges 12x YoY (~6x adjusted) as credit costs normalise
PAT +1215.3% YoY · revenue +19.7% · margins expanding
₹668.64 Cr
+19.7% YoY
₹81.34 Cr
+1215.3% YoY
12.13%
+11pp YoY
₹4.85
Muthoot Microfin's standalone PAT for Q1 FY27 came in at ₹81.3 Cr, up ~1215% YoY (~12x reported) and +14.4% QoQ from ₹71.1 Cr. Adjusted for a ₹7.36 Cr one-off derecognition loss that had depressed the year-ago (Q1 FY26) quarter's PBT, underlying YoY PAT growth is a still-strong ~501% (~6x) — the reported multiple overstates the recovery, but the base quarter was itself a genuine microfinance-sector credit-cost trough, not an accounting artefact alone. Revenue from operations was ₹668.6 Cr (+19.7% YoY, +5.8% QoQ); total income of ₹670.6 Cr was up 20.0% YoY per the company's own disclosure. Net profit margin expanded to 12.13% from 1.11% a year ago (roughly flat q/q versus 11.13% in Q4 FY26), and the PBT margin rose to 15.90% from just 1.03% in Q1 FY26.
Q1 FY-2027 vs prior quarters
The swing was driven almost entirely by credit costs, not topline: the impairment charge fell to ₹91.85 Cr from ₹125.38 Cr a year earlier despite 18% AUM growth, taking credit cost to 2.6% — below the company's own FY27 guided range of 2.7–3%. GNPA improved 115 bps YoY and 19 bps QoQ to 3.70%, NNPA improved 53 bps YoY and 10 bps QoQ to 1.05%, and collection efficiency rose 497 bps YoY to 97.97%. Finance costs rose 17.6% YoY to ₹246.7 Cr in line with AUM growth to ₹14,457 Cr (+18% YoY, +3.2% QoQ), even as the average cost of borrowing eased to 10.13% from 10.27% in FY26.
The stock went into the print at ₹221.94, up 7.5% over the past month of trading.
For context: this is the second-highest quarterly PAT of the last 6 quarters; PAT has now risen for 5 consecutive quarters.
Management unveils 'Vision 3030,' targeting INR 30,000 crores AUM by 2030 through a strategic pivot towards diversified products, aiming for a 47% non-JLG portfolio mix. The company guides for long-term sustainable profitability with an ROA of 5%+ and ROE of 20%+, driven by NIM expansion to over 13.5%, opex reduction,
— This quarter: beat
No Q1-specific street estimate for Muthoot Microfin was found; the only available consensus (Trendlyne, 2-analyst panel) pegs full-year FY27 profit growth at ~106%, a full-year figure that isn't directly comparable to this quarter's print. Against the prior (Q4 FY26) concall's confident tone and Vision 3030 targets (₹30,000 Cr AUM by FY30, ROA 5%+, ROE 20%+, NIM above 13.5%, credit cost ~2.5%), this quarter is directionally consistent but still well short on the long-run metrics: ROA improved 209 bps YoY to 2.3%, ROE improved 1,029 bps YoY to 11.2%, and NIM held at 12.0% — all trailing the FY30 aspirations, as expected this early in a multi-year build. This quarter's regulatory/funding developments — a ₹35 Cr commercial paper allotment and a SEBI exemption from open-offer requirements — were procedural and not tied to the earnings print. More directly relevant to the Vision 3030 diversification push, the company commenced gold-loan disbursements under a co-lending partnership with parent Muthoot Fincorp during the quarter, and the Non-JLG portfolio mix rose to 24% (still well below the 47% long-term target). CEO Sadaf Sayeed attributed the quarter to 'strong traction in our Non-JLG segment' and collection-efficiency gains; the numbers bear this out, with credit cost coming in below guidance and asset quality improving on every metric the company tracks.
W1
Credit cost trajectory toward management's long-run ~2.5% target vs 2.6% delivered this quarter (already inside the FY27 guided 2.7-3% band)
W2
NIM at 12.0% vs the Vision 3030 target of over 13.5% — watch for expansion path over coming quarters
W3
Non-JLG portfolio mix progression from 24% currently toward the 47% long-term Vision 3030 target
Figures reported in INR millions in the filing; converted to ₹ Crore (÷10). Standalone only — company has no subsidiary/associate/JV as of Jun-30-2026, so no consolidated statement exists. Q1 FY26 (year-ago) PBT included a one-off ₹7.36 Cr 'net loss on derecognition of financial instrument under amortised cost category' absent in both the current and immediately-prior quarter; adjusted for this, YoY PAT growth is ~501% (~6x) vs ~1215% (~12x) reported. Limited-review (unaudited) financials.
Informational and educational content only. Not investment advice.